Opus Genetics is trading at $4.24, up +11.58%, as broader risk appetite improved after Nvidia beat expectations.
- No new Opus Genetics company-specific announcement was identified for August 27, 2026; latest listed releases remain the August 19 inducement grants and earlier quarterly update.
- Nvidiaβs results lifted S&P 500 futures and Asian stocks overnight.
- The move follows a 7.54% decline to $3.80 on August 26, suggesting a sharp rebound rather than a confirmed company catalyst.